Ascendis Pharma Price Target Maintained With a $287.00/Share by Raymond James
Ratings actions from Benzinga: GMT) Ascendis Pharma Cut to Outperform From Strong Buy by Raymond JamesRatings actions from Benzinga
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.